GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.8416 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.9437 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, EPHX2, ERBB2, ESR1, FABP3, FABP4, FDPS, HSD17B1, HSD17B2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
10.477 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
9.80443 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
9.7696 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, FDPS, NISCH, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
8.87923 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, EPHX2, ERBB2, ESR1, FABP3, FABP4, FDPS, FLT3, HASPIN, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NISCH, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, SRC, TYR, XDH |
7.98527 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, PTGS1, PTGS2 |
7.79127 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, EGFR, EPHX2, ESR1, FABP3, FABP4, FLT3, HCAR2, HSD17B1, HSD17B2, KDR, MAOA, MET, NISCH, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS1, PTGS2, SRC, XDH |
7.54931 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, PTGS1, PTGS2 |
7.25454 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, EPHX2, ERBB2, FABP3, FABP4, FDPS, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
7.17768 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
7.12816 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CLK1, CSNK2A1, DYRK1A, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
7.12816 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, PTGS1, PTGS2 |
7.05479 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIM1, PRKCA, SRC |
6.58958 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
6.42572 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.32187 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CHRM1, CHRM3, CHRM5, CLK1, CYP1A1, EGFR, ERBB2, ESR1, FLT3, MET, PIK3CB, PIM1, SRC, TYR |
6.31932 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, EPHX2, ERBB2, ESR1, FABP3, FABP4, FDPS, FLT3, HASPIN, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, SRC, TYR, XDH |
6.23058 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
6.05414 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
5.95353 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, PTGS1, PTGS2 |
5.93857 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, PTGS1, PTGS2 |
5.75967 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DYRK3, EGFR, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, SRC, XDH |
5.73363 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, HCAR2, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
5.70756 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, EPHX2, ERBB2, FDPS, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, SRC, XDH |
5.69268 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, HCAR2, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
5.69042 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DYRK1A, DYRK2, DYRK3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
5.63859 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DYRK3, EGFR, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, SRC, XDH |
5.63355 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, PPARA, PTGS1, PTGS2 |
5.57059 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PRKCA, SRC |
5.5558 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, EPHX2, ERBB2, FDPS, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, SRC, XDH |
5.35426 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, FDPS, HSD17B1, HSD17B2 |
5.25934 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, SRC |
5.21583 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, DYRK2, DYRK3, EGFR, ERBB2, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, NISCH, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
5.18718 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, CHRM1, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS1, PTGS2, SRC, XDH |
5.14592 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HSD17B1, HSD17B2, PRKCA |
5.13534 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
5.12639 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, DYRK3, EGFR, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, SRC |
5.12636 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, DYRK2, DYRK3, EGFR, ERBB2, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, NISCH, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
5.09163 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DYRK3, EGFR, ESR1, FLT3, HCAR2, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, SRC, XDH |
5.07824 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, PIK3CA, PPARA, PRKCA, PTGS2, SRC, TYR |
4.97994 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, DYRK3, EGFR, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, SRC |
4.8845 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, CA2, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, DYRK1B, DYRK3, EGFR, ERBB2, ESR1, FABP4, FLT3, HSD17B2, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, SRC, TYR |
4.84305 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, EPHX2, FABP3, FDPS, FLT3, HCAR2, PPARA, PTGS2, SRC |
4.80149 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, HSD17B2, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTGS2, SRC, TYR |
4.79376 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, MAOA, NQO2, PTGS1, PTGS2, TYR, XDH |
4.73757 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGS2, SRC |
4.7247 |
[BP] GO:0003018 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2, PTGS2, SRC |
4.70031 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, FLT3, HSD17B2, KDR, PIK3CA, PPARA, SRC, TYR |
4.5871 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.56393 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2, ERBB2, ESR1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, MMP9, PIK3CA, PPARA, PRKCA, PTGS2, SRC, TYR |
4.53374 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, EPHX2, NQO2, PTGS1 |
4.42284 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HSD17B2, PTGS2, SRC, TYR |
4.3664 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, AXL, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
4.29954 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, DYRK3, EGFR, IGF1R, KDR, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, SRC |
4.27222 |
[BP] GO:0038128 |
None
|
EGFR, ERBB2, PIK3CA, PRKCA, SRC |
4.23316 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.23208 |
[BP] GO:0097746 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2, PTGS2 |
4.21117 |
[BP] GO:0035296 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2, PTGS2 |
4.21117 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.1998 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CHRM1, CSNK2A1, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS2 |
4.10897 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CHRM1, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MMP9, NISCH, PRKCA, PTGS2, SRC |
4.08366 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, AXL, CA2, CA7, CACNA1C, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DYRK2, EGFR, ERBB2, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, NISCH, PIK3CB, PPARA, PRKCA, PTGS2, SRC |
4.08366 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AXL, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DYRK1A, DYRK1B, EGFR, ERBB2, ESR1, FLT3, HSD17B2, KDR, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, TYR |
4.08366 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA |
4.08366 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CACNA1C, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MMP9, NISCH, PRKCA, PTGS2, SRC |
4.08366 |
[BP] GO:0050880 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2, PTGS2 |
4.07002 |
[BP] GO:0035150 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2, PTGS2 |
4.05601 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
4.03349 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DYRK1A, DYRK1B, DYRK2, EGFR, ERBB2, ESR1, FABP3, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, SRC, XDH |
3.97083 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, SRC |
3.9658 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, CA2, CA7, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DYRK1A, DYRK1B, DYRK2, EGFR, EPHX2, ERBB2, ESR1, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, SRC, XDH |
3.94903 |
[BP] GO:0003013 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2, PTGS2, SRC |
3.93599 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, CHRM1, CHRM2, CHRM3, EGFR, PTGS2 |
3.89146 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, AXL, CA12, CA2, CA7, CACNA1C, EGFR, EPHX2, ESR1, FABP3, FABP4, FLT3, MET, PIK3CA, PIK3CB, SRC |
3.86482 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
3.86276 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, MET, PIK3CA, PIK3CB, SRC, XDH |
3.86006 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CACNA1C, EGFR, HCAR2, KDR, PIK3CB, PTGS2, SRC |
3.85255 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, PPARA, PTGS1, PTGS2 |
3.82047 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MMP9, NISCH, PRKCA, PTGS2, SRC |
3.80709 |
[BP] GO:0008217 |
None
|
ADORA1, ADRB1, EPHX2, NISCH, PPARA, PTGS1, PTGS2 |
3.78336 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, MET, PIK3CA, PIK3CB, SRC |
3.72866 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.68615 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.68615 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ERBB2, ESR1, FABP3, FLT3, IGF1R, MMP2, PPARA, PTGS2, SRC |
3.64725 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.61501 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.61251 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.61251 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, ALOX5, AXL, CACNA1C, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, EGFR, EPHX2, ESR1, FABP4, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, SRC, TYR |
3.52251 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, CHRM1, CHRM2, CHRM3, EGFR, HCAR2, PRKCA, PTGS2 |
3.52251 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.44465 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.42386 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, EGFR, IGF1R, KDR, MET, MMP9, NISCH, PRKCA, PTGS2, SRC |
3.39144 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, PPARA, PTGS2, SRC |
3.33734 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EPHX2, FABP3, FABP4, MAOA, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
3.31629 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, PTGS2 |
3.2942 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AURKB, AXL, CA2, CA6, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DYRK2, EGFR, EPHX2, ERBB2, ESR1, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS1, PTGS2, SRC, TYR |
3.23878 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
ERBB2, IGF1R, PIK3CA, PIK3CB |
3.2239 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CACNA1C, CHRM1, DYRK2, EGFR, ERBB2, HCAR2, MMP12, PRKCA, PTGS2, SRC |
3.2003 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, NISCH |
3.17566 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.15762 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PTGS2, SRC |
3.14206 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.12056 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5 |
3.01827 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
3.01827 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FLT3, PTGS2, SRC, TYR |
2.98182 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, EPHX2, ERBB2, ESR1, FABP3, FABP4, FDPS, FLT3, HASPIN, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NISCH, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, SRC, TYR, XDH |
2.98126 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
CLK1, CSNK2A1, DYRK1A, HASPIN, PRKCA |
2.97226 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.97226 |
[BP] GO:0038127 |
None
|
EGFR, ERBB2, PIK3CA, PRKCA, SRC |
2.84867 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, AXL, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
2.84561 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, PIK3CA, PTGS2, SRC |
2.84413 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, MET, PIK3CA, PIK3CB |
2.83173 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.83173 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
CLK1, CSNK2A1, DYRK1A, HASPIN, PRKCA |
2.81578 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.77628 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, ESR1 |
2.77135 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, AURKB, AXL, CHRM1, CHRM3, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, EPHX2, ERBB2, ESR1, FABP3, FABP4, FDPS, FLT3, HASPIN, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, SRC, TYR, XDH |
2.75879 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, HCAR2, PIK3CB, PTGS2 |
2.75458 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.74859 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, CA2, CA7, CACNA1C, CHRM1, CYP19A1, DYRK2, EGFR, ERBB2, HCAR2, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PTGS2, SRC |
2.74859 |
[BP] GO:0090257 |
None
|
ADORA1, CACNA1C, CHRM1, CHRM2, CHRM3, PRKCA, PTGS2 |
2.73706 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRB1, AKR1B1, AXL, CACNA1C, CYP1B1, DYRK2, EGFR, ERBB2, HASPIN, IGF1R, KDR, MET, NISCH, PIK3CA, PIK3CB, PRKCA, SRC |
2.71806 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
2.6978 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AXL, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, PIK3CA, PTGS2, SRC |
2.69055 |
[BP] GO:0007188 |
None
|
ADORA1, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5 |
2.67034 |
[BP] GO:0006937 |
None
|
ADORA1, CACNA1C, CHRM1, CHRM2, CHRM3, PTGS2 |
2.59742 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, CACNA1C, EGFR, EPHX2, ESR1, FABP3, FABP4, MET, PIK3CA, PIK3CB |
2.59196 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.59192 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, CHRM5, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, SRC, XDH |
2.59192 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.59097 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, AXL, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CYP1B1, EGFR, ERBB2, ESR1, HCAR2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, SRC, XDH |
2.5892 |
[BP] GO:0030258 |
lipid modification
|
CYP1A1, EGFR, EPHX2, ERBB2, MET, PIK3CA, PIK3CB |
2.5866 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.58633 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, CHRM5, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, SRC, XDH |
2.56623 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, EGFR, ERBB2, FABP3, FLT3, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
2.56623 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, EGFR, ERBB2, FABP3, FLT3, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
2.56623 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, AURKB, AXL, CHRM1, CHRM3, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, EPHX2, ERBB2, ESR1, FABP3, FABP4, FDPS, FLT3, HASPIN, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NISCH, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, SRC, TYR, XDH |
2.56623 |
[BP] GO:0046854 |
phosphatidylinositol phosphorylation
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.55604 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AURKB, AXL, CHRM1, CHRM3, CLK1, CSNK2A1, CYP1A1, CYP1A2, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, ESR1, FLT3, HASPIN, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, SRC, TYR, XDH |
2.55399 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, PTGS1, PTGS2, SRC |
2.54606 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, PIM1, PPARA, PTGS1, PTGS2, TYR |
2.52966 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2 |
2.50784 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, AXL, CA1, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DYRK2, EGFR, ERBB2, ESR1, FLT3, HASPIN, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, NISCH, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, SRC |
2.50784 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.48446 |
[BP] GO:0048731 |
system development
|
ACHE, ADORA1, CACNA1C, CHRM1, CHRM2, CHRM3, DYRK1A, ERBB2, MMP9, PIK3CA, SRC |
2.48446 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PRKCA, PTGS2 |
2.48446 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, AURKB, AXL, CSNK2A1, CYP1B1, DYRK1A, DYRK2, DYRK3, EGFR, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
2.47934 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.46781 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP12, MMP2, MMP9 |
2.44605 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.44353 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.44353 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, DYRK1A, DYRK3, EGFR, ESR1, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PRKCA, PTGS2, SRC, XDH |
2.4363 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, FDPS |
2.4363 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, EGFR, ERBB2, PPARA |
2.41661 |
[BP] GO:0030168 |
platelet activation
|
AXL, PIK3CA, PIK3CB, PRKCA, SRC |
2.38445 |
[BP] GO:0046834 |
lipid phosphorylation
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
2.36874 |
[BP] GO:0007187 |
None
|
ADORA1, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5 |
2.36874 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PTGS2, SRC |
2.35101 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.29921 |
[BP] GO:0019229 |
None
|
CHRM1, CHRM3, EGFR, PTGS2 |
2.25449 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KDR, PTGS2, SRC |
2.25351 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, AKR1B1, MET, PIK3CA |
2.25351 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, EGFR, ESR1, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, SRC |
2.25019 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.24332 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DYRK1A, EGFR, ESR1, PPARA, SRC |
2.24332 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.24097 |
[BP] GO:0048015 |
phosphatidylinositol-mediated signaling
|
ERBB2, IGF1R, PIK3CA, PIK3CB |
2.24097 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DYRK1A, DYRK2, DYRK3, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, SRC, XDH |
2.22175 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, EGFR, PTGS2 |
2.21466 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.20091 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, EGFR, ERBB2, FLT3, KDR, PIK3CB, PRKCA, SRC, XDH |
2.19326 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.19326 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.19326 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.19326 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.19326 |
[BP] GO:0048017 |
inositol lipid-mediated signaling
|
ERBB2, IGF1R, PIK3CA, PIK3CB |
2.17674 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, FDPS |
2.1635 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DYRK1A, DYRK3, ESR1, IGF1R, MET, MMP9, PTGS2, SRC, XDH |
2.16065 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.15981 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.15722 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, FDPS, HSD17B1, HSD17B2 |
2.15398 |
[BP] GO:0051223 |
None
|
ACHE, CACNA1C, CHRM1, DYRK2, EGFR, ERBB2, HCAR2, MMP12, PRKCA, PTGS2, SRC |
2.13921 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, KDR, MET, MMP12, PPARA, PRKCA, PTGS2 |
2.13598 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.12669 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, EGFR, NISCH, PTGS2 |
2.12371 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, EGFR, NISCH, PTGS2 |
2.12371 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, KDR, SRC |
2.11758 |
[BP] GO:0006644 |
phospholipid metabolic process
|
ACHE, CSNK2A1, EGFR, ERBB2, FDPS, MET, PIK3CA, PIK3CB |
2.11535 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, EPHX2, MAOA |
2.10961 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, EGFR, ERBB2, FLT3, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC, XDH |
2.06061 |
[BP] GO:0010632 |
regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PTGS2, SRC |
2.04691 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, SRC |
2.0096 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, AURKB, CSNK2A1, DYRK1A, DYRK1B, DYRK2, EGFR, EPHX2, ERBB2, ESR1, FABP3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, SRC, XDH |
2.0096 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.0096 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, CHRM3, EGFR, ERBB2 |
3.22495 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, MET, PTGS2, SRC |
2.48446 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRB1, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, EGFR, ERBB2, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, MMP2, NISCH, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
2.48446 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX5, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, ESR1, FLT3, HCAR2, HSD17B2, IGF1R, KDR, MAOA, MET, MMP2, NISCH, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, SRC, TYR |
1.91322 |
[CC] GO:0045202 |
None
|
ACHE, CHRM1, CHRM2, CHRM3, CHRM5, EGFR |
1.69922 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
17.0253 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, EPHX2, ERBB2, FDPS, FLT3, HASPIN, HSD17B1, HSD17B2, IGF1R, KDR, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, SRC, TYR, XDH |
14.7968 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM3, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, EPHX2, ERBB2, ESR1, FABP3, FABP4, FDPS, FLT3, HASPIN, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NISCH, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, SRC, TYR, XDH |
14.1771 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK2, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PRKCA, TYR, XDH |
13.5143 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, SRC |
11.1297 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.9437 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
9.91636 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.7696 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIM1, PRKCA, SRC |
9.00544 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
8.66577 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
7.98953 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
6.88453 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.58958 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
6.32187 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.32187 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
6.25517 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK2, DYRK3, EPHX2, ESR1, FDPS, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PRKCA, PTGS1, PTGS2, TYR, XDH |
6.23058 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
6.12128 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.95353 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PRKCA |
5.95353 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, MAOA, NQO2, PTGS1, PTGS2, TYR, XDH |
5.75967 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, TYR |
5.75967 |
[MF] GO:0004712 |
protein serine/threonine/tyrosine kinase activity
|
AURKB, CLK1, DYRK1A, DYRK1B, DYRK2, DYRK3 |
5.53631 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK2, DYRK3, EPHX2, ESR1, FDPS, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PRKCA, PTGS1, PTGS2, TYR, XDH |
5.40296 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.35426 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.25934 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.88157 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
AURKB, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, HASPIN, PIK3CA, PIM1, PRKCA |
4.80037 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FABP3, FABP4, FLT3, HASPIN, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, XDH |
4.67374 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
4.60462 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
4.5871 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH |
4.55336 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
4.44351 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
4.407 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, XDH |
4.08366 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, HSD17B1, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, XDH |
4.08366 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.06614 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.98788 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, EGFR, HSD17B1, IGF1R, NQO2 |
3.97174 |
[MF] GO:0043168 |
anion binding
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FABP3, FABP4, FLT3, HASPIN, HSD17B1, IGF1R, KDR, MET, NISCH, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, XDH |
3.86482 |
[MF] GO:0008227 |
None
|
ADRB1, CHRM1, CHRM2, CHRM3, CHRM5 |
3.54764 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
3.39167 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PRKCA, SRC |
3.32771 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.27312 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
3.26733 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.263 |
[MF] GO:0032555 |
purine ribonucleotide binding
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
3.263 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, PPARA |
3.22996 |
[MF] GO:0017076 |
purine nucleotide binding
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
3.22909 |
[MF] GO:0032553 |
ribonucleotide binding
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
3.2243 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
3.2003 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.07869 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
EGFR, ERBB2, MET, PIK3CA, PIK3CB |
3.06726 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.03429 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
2.90565 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ADORA1, AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
2.86834 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.81582 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.81582 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, PPARA |
2.6397 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET |
2.57351 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET |
2.57351 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, HASPIN, PRKCA |
2.5362 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, PPARA |
2.50784 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, KDR, MMP12, MMP9, NISCH, PIM1, PPARA, SRC |
2.45069 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, CSNK2A1, DYRK1A, EGFR, EPHX2, ERBB2, ESR1, FLT3, IGF1R, KDR, MET, MMP9, NISCH, NQO2, PTGS2, TYR, XDH |
2.44544 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.41883 |
[MF] GO:0016740 |
transferase activity
|
AURKB, AXL, CLK1, CSNK2A1, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, FDPS, FLT3, HASPIN, IGF1R, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC |
2.25351 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, ESR1, FLT3, HCAR2, IGF1R, KDR, MET, PPARA |
2.21024 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, KDR, MMP12, MMP9, NISCH, PPARA, SRC |
2.09884 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.02666 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRB1, AURKB, AXL, CLK1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DYRK1A, DYRK1B, DYRK2, DYRK3, EGFR, ERBB2, ESR1, FDPS, FLT3, HASPIN, HSD17B1, IGF1R, KDR, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, SRC, XDH |
2.00988 |